PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron

Signal Transduct Target Ther. 2022 May 24;7(1):167. doi: 10.1038/s41392-022-01025-8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Drug Treatment*
  • Humans
  • Phosphatidylinositol 3-Kinases
  • SARS-CoV-2*

Substances

  • PIKFYVE protein, human